Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection-Reference-Cited by-同舟云学术

Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection

Published:1988-07 Issue:2 Volume:455 Page:332-345
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Janson Ann Marie,Fuxe Kjell,Agnati Luigi F.,Kitayama Isao,Härfstrand Anders,Andersson Kurt,Goldstein Menek

Publisher

Elsevier BV

Subject

Developmental Biology,Clinical Neurology,Molecular Biology,General Neuroscience

Reference43 articles.

1. Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting;Agnati;Acta Physiol. Scand.,1983

2. Effects of single injections of nicotine on the ascending dopamine pathways in the rat;Andersson;Acta Physiol. Scand.,1981

3. Effects of acute central and peripheral administration of nicotine on ascending dopamine pathways in the male rat brain. Evidence of nicotine induced increases of dopamine turnover in various telencephalic dopamine nerve terminal systems;Andersson;Med. Biol.,1981

4. Cigarette smoking and Parkinson's disease; part 1. A comparison of cases with matched neighbors;Baumann;Neurology,1980

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conventional and Novel Pharmacological Approaches to Treat Dopamine-Related Disorders: Focus on Parkinson’s Disease and Schizophrenia;Neuroscience;2020-07

2. The neuroprotective effect of nicotine in Parkinson’s disease models is associated with inhibiting PARP-1 and caspase-3 cleavage;PeerJ;2017-10-19

3. Regulation of Gait and Balance: The Underappreciated Role of Neuronal Nicotinic Receptor Agonists;Current Pharmaceutical Design;2016-04-27

4. Alpha7 nicotinic receptors as therapeutic targets for Parkinson's disease;Biochemical Pharmacology;2015-10

5. Activation of α7 nicotinic acetylcholine receptors protects astrocytes against oxidative stress-induced apoptosis: Implications for Parkinson's disease;Neuropharmacology;2015-04